202 related articles for article (PubMed ID: 28216637)
21. Distinctive role of KV1.1 subunit in the biology and functions of low threshold K(+) channels with implications for neurological disease.
Ovsepian SV; LeBerre M; Steuber V; O'Leary VB; Leibold C; Oliver Dolly J
Pharmacol Ther; 2016 Mar; 159():93-101. PubMed ID: 26825872
[TBL] [Abstract][Full Text] [Related]
22. Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.
Yuan H; Yuan H; Wang Q; Ye W; Yao R; Xu W; Liu Y
Mol Genet Genomic Med; 2020 Oct; 8(10):e1434. PubMed ID: 32705822
[TBL] [Abstract][Full Text] [Related]
23. Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.
Tristán-Clavijo E; Scholl FG; Macaya A; Iglesias G; Rojas AM; Lucas M; Castellano A; Martinez-Mir A
Mov Disord; 2016 Nov; 31(11):1743-1748. PubMed ID: 27477325
[TBL] [Abstract][Full Text] [Related]
24. An activator of voltage-gated K
Servettini I; Talani G; Megaro A; Setzu MD; Biggio F; Briffa M; Guglielmi L; Savalli N; Binda F; Delicata F; Bru-Mercier G; Vassallo N; Maglione V; Cauchi RJ; Di Pardo A; Collu M; Imbrici P; Catacuzzeno L; D'Adamo MC; Olcese R; Pessia M
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2207978120. PubMed ID: 37487086
[TBL] [Abstract][Full Text] [Related]
25. Action potential broadening in a presynaptic channelopathy.
Begum R; Bakiri Y; Volynski KE; Kullmann DM
Nat Commun; 2016 Jul; 7():12102. PubMed ID: 27381274
[TBL] [Abstract][Full Text] [Related]
26. Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.
Heeroma JH; Henneberger C; Rajakulendran S; Hanna MG; Schorge S; Kullmann DM
Dis Model Mech; 2009; 2(11-12):612-9. PubMed ID: 19779067
[TBL] [Abstract][Full Text] [Related]
27. A patient with episodic ataxia and paramyotonia congenita due to mutations in KCNA1 and SCN4A.
Rajakulendran S; Tan SV; Matthews E; Tomlinson SE; Labrum R; Sud R; Kullmann DM; Schorge S; Hanna MG
Neurology; 2009 Sep; 73(12):993-5. PubMed ID: 19770477
[No Abstract] [Full Text] [Related]
28. Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency.
Zerr P; Adelman JP; Maylie J
J Neurosci; 1998 Apr; 18(8):2842-8. PubMed ID: 9526001
[TBL] [Abstract][Full Text] [Related]
29. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
Tomlinson SE; Rajakulendran S; Tan SV; Graves TD; Bamiou DE; Labrum RW; Burke D; Sue CM; Giunti P; Schorge S; Kullmann DM; Hanna MG
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1107-12. PubMed ID: 23349320
[TBL] [Abstract][Full Text] [Related]
30. Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.
Manville RW; Abbott GW
J Pharmacol Exp Ther; 2020 Jun; 373(3):391-401. PubMed ID: 32217768
[TBL] [Abstract][Full Text] [Related]
31. Native American ataxia medicines rescue ataxia-linked mutant potassium channel activity via binding to the voltage sensing domain.
Manville RW; Alfredo Freites J; Sidlow R; Tobias DJ; Abbott GW
Nat Commun; 2023 Jun; 14(1):3281. PubMed ID: 37280215
[TBL] [Abstract][Full Text] [Related]
32. A novel mutation in KCNA1 causes episodic ataxia without myokymia.
Lee H; Wang H; Jen JC; Sabatti C; Baloh RW; Nelson SF
Hum Mutat; 2004 Dec; 24(6):536. PubMed ID: 15532032
[TBL] [Abstract][Full Text] [Related]
33. The voltage-gated K+ channel subunit Kv1.1 links kidney and brain.
Ellison DH
J Clin Invest; 2009 Apr; 119(4):763-6. PubMed ID: 19348045
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
Chen H; von Hehn C; Kaczmarek LK; Ment LR; Pober BR; Hisama FM
Neurogenetics; 2007 Apr; 8(2):131-5. PubMed ID: 17136396
[TBL] [Abstract][Full Text] [Related]
35. Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1.
Rea R; Spauschus A; Eunson LH; Hanna MG; Kullmann DM
J Physiol; 2002 Jan; 538(Pt 1):5-23. PubMed ID: 11773313
[TBL] [Abstract][Full Text] [Related]
36. Expression in mammalian cells and electrophysiological characterization of two mutant Kv1.1 channels causing episodic ataxia type 1 (EA-1).
Bretschneider F; Wrisch A; Lehmann-Horn F; Grissmer S
Eur J Neurosci; 1999 Jul; 11(7):2403-12. PubMed ID: 10383630
[TBL] [Abstract][Full Text] [Related]
37. Editing inducer elements increases A-to-I editing efficiency in the mammalian transcriptome.
Daniel C; Widmark A; Rigardt D; Öhman M
Genome Biol; 2017 Oct; 18(1):195. PubMed ID: 29061182
[TBL] [Abstract][Full Text] [Related]
38. Episodic ataxia/myokymia mutations functionally expressed in the Shaker potassium channel.
Boland LM; Price DL; Jackson KA
Neuroscience; 1999; 91(4):1557-64. PubMed ID: 10391459
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.
Dinoi G; Morin M; Conte E; Mor Shaked H; Coppola MA; D'Adamo MC; Elpeleg O; Liantonio A; Hartmann I; De Luca A; Blunck R; Russo A; Imbrici P
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897654
[TBL] [Abstract][Full Text] [Related]
40. Functional Differences Between Two Kv1.1 RNA Editing Isoforms: a Comparative Study on Neuronal Overexpression in Mouse Prefrontal Cortex.
Zhang L; Peng Z; Bian W; Zhu P; Tang B; Liao WP; Su T
Mol Neurobiol; 2021 May; 58(5):2046-2060. PubMed ID: 33411244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
